Autoimmune diseases occur when the immune system (normally responsible for fighting infections) mistakenly attacks the body’s own tissues. This misdirected response can cause inflammation, pain, fatigue, and damage to organs or entire systems. More than 80 autoimmune conditions have been identified by medical professionals, but some are far more common and better understood than others.
Roche AG has reported strong results from a mid-stage clinical trial of its experimental weight loss drug, CT-388, showing that study subjects lost an average of 22.5% of their body weight after 48 weeks of observation. Based on these findings, the company plans to move the drug into large Phase 3 trials later this year.
A small but groundbreaking new study hints that gene editing may one day offer a permanent fix for dangerously high cholesterol. Published in the New England Journal of Medicine, the pilot trial tested a CRISPR-Cas9–based treatment in 15 people with severe cholesterol problems. CRISPR works like tiny biological scissors, cutting and switching off specific genes.
A new clinical trial has some exciting news for people with type 2 diabetes: a daily pill utilizing the molecule orforglipron helped participants lose almost as much weight as popular injectable drugs like Ozempic. And because it’s taken orally, it could make treatment much simpler and more accessible. The study followed more than 1,600 adults across 10
A groundbreaking study from the University of Auckland has found that a single fecal microbiota transplant (FMT) can provide obese teenagers with years of health benefits. FMT involves transferring gut bacteria from healthy donors to patients—in this case, through capsules swallowed over two days. While the idea may sound unappealing, the results are remarkable. The
Eli Lilly is moving closer to bringing its experimental weight loss pill, orforglipron, to market after releasing positive results from its latest phase 3 clinical trial. The study, called Attain-2, tested the once-daily pill in people who are overweight or obese and also have Type 2 diabetes—a group often harder to treat. The trial found
A large new study suggests that verbal abuse during childhood can be just as harmful to long-term mental health as physical abuse—and in some cases, even worse. Researchers from Liverpool John Moores University analyzed data from over 20,000 adults in England and Wales collected between 2012 and 2024. Participants reported whether they had experienced verbal
A major new study has found that drinking just one can of diet soda a day may raise your risk of developing type 2 diabetes by 38%. Surprisingly, this is a greater risk than what’s seen with regular sugary sodas. The study, led by researchers at Monash University, followed more than 36,000 adults aged 40
A recent clinical trial is offering new hope in the fight against HIV. Researchers tested a new type of vaccine using mRNA technology—the same method used in COVID-19 vaccines—to see if it could trigger strong immune responses against the virus. The trial, called HVTN 302, tested three different versions of an HIV vaccine in 108
A major new study from Denmark shows no link between aluminum in childhood vaccines and an increased risk of diseases like asthma or autism. Researchers examined health and vaccination records of over 1.2 million children from 1997 to 2018. They found no evidence that aluminum-containing vaccines cause harm. Aluminum salts are added to some vaccines
